Cindy Jacobs
2011
In 2011, Cindy Jacobs earned a total compensation of $479.8K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $99,750 |
|---|---|
| Salary | $380,000 |
| Total | $479,750 |
Jacobs received $380K in salary, accounting for 79% of the total pay in 2011.
Jacobs also received $99.8K in non-equity incentive plan.
Rankings
In 2011, Cindy Jacobs' compensation ranked 8,184th out of 10,747 executives tracked by ExecPay. In other words, Jacobs earned more than 23.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,184 out of 10,747 | 24th |
Division Manufacturing | 3,011 out of 3,960 | 24th |
Major group Chemicals And Allied Products | 748 out of 1,033 | 28th |
Industry group Drugs | 538 out of 781 | 31st |
Industry In Vitro and In Vivo Diagnostic Substances | 27 out of 43 | 37th |
Source: SEC filing on April 24, 2014.
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2011.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019